De COGEM heeft een nieuwe signalering gepubliceerd, waarin zij verkent hoeveel nieuwe gentherapieën in de pijplijn zitten, wat de kosten zijn, en de dilemma’s en keuzes die met de komst van deze therapieën gepaard gaan. Ook wordt ingegaan op de instrumenten die de overheid heeft om gentherapieën betaalbaar en beschikbaar te houden.
Lees het document hier.
The Netherlands Commission on Genetic Modification (COGEM) commissions third-party research to support its work. The following project is open for enrollment: Germline modification and new gene therapies; an exploration. This project is a collaboration with the Central Committee on Research Involving Human Subjects (CCMO), and aims to gain insight into the likelihood of unintended germline modification in new (non-viral) gene therapies to support risk analysis. Interested parties are invited to submit a project bid. More information can be read here.
ZonMw, heeft, in nauwe samenwerking met het Centre for Future Affordable Sustainable Therapies development (FAST), een onderzoek geleid naar ATMP’s* in Nederland. Dit onderzoek is onderdeel van het ZonMw-deelprogramma Regulatoire Pandemische Paraatheid. Er is een overzicht gecreëerd van stakeholders, wet- en regelgeving, marktregistratie- en vergoedingsroutes, knelpunten en oplossingsrichtingen, en initiatieven omtrent de markttoegang (registratie en vergoeding) van ATMP’s.
Het rapport biedt handvatten en aanbevelingen voor ontwikkelaars, beoordelaars, beleidsmakers, zorgprofessionals en andere geïnteresseerden binnen het nationale ATMP-veld en hoopt daarmee bij te dragen aan de snelle inzetbaarheid van ATMP’s.
*ATMP’s: Advanced Therapy Medicinal Products, ook wel Geneesmiddelen voor geavanceerde therapie.
The deadline for abstract submissions for the ESGCT Annual Congress (24-27 October, Brussels, Belgium) has been extended to 30 June 2023. There will be no further extension added to this date.
Free registration is offered to student members who submit an abstract which is accepted for an oral or poster presentation. Register by 30 June to get Early Bird rates, plus reduced registration fees will apply to all ESGCT members. NVGCT members are entitled to free membership of the ESGCT for 2023, which can be requested via events@esgct.eu with proof of your NVGCT membership. This proof of NVGCT membership can be acquired via info@nvgct.nl.
FYI: Everyone who registered for this year’s NVGCT Annual Symposium (12-13 June) has automatically become a member of NVGCT.
Registration and abstract submission are now open for the ESGCT 30th Annual Congress. This year’s Congress is being held in collaboration with the SFTCG and NVGCT and takes place from 24-27 October in Brussels, Belgium.
Free registration is offered to student members who submit an abstract which is accepted for an oral or poster presentation. Register by 30 June to get Early Bird rates, plus reduced registration fees will apply to all ESGCT members. NVGCT members are entitled to free membership of the ESGCT for 2023, which can be requested via events@esgct.eu with proof of your NVGCT membership. This proof of NVGCT membership can be acquired via info@nvgct.nl.
Abstract submission deadline: 15 June 2023.
